EORTC QLQ-C15-PAL scalea | Octreotide (N = 52) mean scores (95% CI) | Placebo (N = 54) mean scores (95% CI) | ||||
---|---|---|---|---|---|---|
Baseline | Post-treatment | p-value | Baseline | Post-treatment | p-value | |
Overall quality of lifeb | 22.08 (14.32, 29.85) n = 40 | 30.81 (22.57, 39.05) n = 33 | 0.205 | 31.48 (22.26, 40.70) n = 36 | 32.22 (21.27, 43.18) n = 30 | 0.778 |
Physical functioningb | 27.69 (19.69, 35.69) n = 39 | 32.44 (22.51, 42.36) n = 30 | 0.204 | 31.17 (22.80, 39.53) n = 40 | 30.00 (19.70, 40.27) n = 30 | 0.831 |
Emotional functioningb | 57.65 (47.35, 67.94) n = 36 | 71.80 (60.78, 82.82) n = 26 | 0.059 | 55.25 (45.26, 65.24) n = 35 | 63.22 (50.20, 76.25) n = 29 | 0.074 |
Fatiguec | 74.09 (67.21, 80.97) n = 39 | 71.88 (63.37, 80.40) n = 32 | 0.107 | 74.10 (67.84, 80.35) n = 39 | 71.88 (60.27, 83.48) n = 32 | 0.965 |
Nausea & vomitingc | 73.18 (62.34, 84.01) n = 41 | 40.70 (27.56, 53.83) n = 34 | 0.001 | 60.53 (50.55, 70.51) n = 38 | 35.95 (23.63, 48.26) n = 32 | 0.016 |
Painc | 60.16 (49.33, 71.00) n = 41 | 43.94 (32.23, 55.65) n = 33 | 0.007 | 55.42 (45.01, 65.83) n = 40 | 42.93 (30.48, 55.38) n = 33 | 0.026 |
Dyspnoeac | 40.65 (29.74, 51.56) n = 41 | 32.32 (21.88, 42.76) n = 33 | 0.077 | 36.75 (27.89, 45.62) n = 39 | 27.08 (14.34, 39.83) n = 32 | 0.008 |
Insomniac | 45.83 (34.59, 57.08) n = 40 | 33.33 (22.28, 44.39) n = 33 | 0.013 | 46.67 (34.89, 58.44) n = 40 | 47.92 (32.67, 63.16) n = 32 | 0.868 |
Appetite lossc | 74.17 (62.98, 85.36) n = 40 | 56.25 (43.50, 69.00) n = 32 | 0.034 | 82.05 (74.27, 89.83) n = 39 | 57.58 (43.63, 71.52) n = 33 | 0.002 |
Constipationc | 67.50 (56.05, 78.95) n = 40 | 50.00 (36.19, 63.81) n = 34 | 0.027 | 67.50 (56.31, 78.69) n = 40 | 52.53 (38.35, 66.71) n = 33 | 0.027 |